DEGAS, disease endophenotyping through graph and adjacency metrics: network biomarkers for Parkinson’s disease progression
Parkinson’s disease (PD) progresses heterogeneously, yet no reliable biomarker stratifies patients for individualized care. We developed DEGAS, a machine learning framework applying functional connectivity to identify network-defined PD subtypes. Baseline functional MRI from 336 early-stage patients was stratified by suspected REM sleep behavior disorder (sRBD), a marker of aggressive disease. Adjacency matrices and graph theory metrics were integrated into classifiers, and predictions validated against three-year outcomes. Region-of-interest analyses showed no group differences in connectivity or topology. By contrast, models incorporating graph theory features achieved robust classification (balanced accuracy 0.91–0.93; MCC 0.61–0.78), outperforming adjacency-only models (balanced accuracy 0.79; MCC 0.52). Metrics that represented the basal ganglia-thalamic, temporal-limbic, and cerebello-cortical circuits were the strongest predictors. Patients classified as sRBD-positive showed worse motor outcomes, accelerated autonomic dysfunction, and higher rates of hallucinations, dyskinesias, and depression. The DEGAS framework defines a baseline network signature marking clinically distinct PD subgroups. External validation is required before clinical use is considered.
Authors
- Alfonso Enrique Martinez-Nunez (ORCID: https://orcid.org/0000-0003-4570-7977)
- David E. Vaillancourt (ORCID: https://orcid.org/0000-0002-5663-6476)
- Gregory M. Pontone (ORCID: https://orcid.org/0000-0002-9540-6913)
- Michael S. Okun (ORCID: https://orcid.org/0000-0002-6247-9358)
- Angelos Barmpoutis (ORCID: https://orcid.org/0000-0003-3271-7965)
- Joshua K. Wong (ORCID: https://orcid.org/0000-0002-4632-3417)
Institutions
- University of Florida Health (US)
- University of Florida (US)
Publication Details
- Journal
- npj Parkinson s Disease
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1038/s41531-026-01602-6
- Primary Topic
- Functional Brain Connectivity Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Michael J. Fox Foundation for Parkinson's Research
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Sanofi
- Biogen
- Teva Pharmaceutical Industries
- Celgene
- Jazz Pharmaceuticals
- Neurocrine Biosciences
- Verily Life Sciences
- Aligning Science Across Parkinson’s
- Voyager Therapeutics
- Weston Family Foundation
- Servier
- H. Lundbeck A/S
- Sun Pharma
- Genentech
- Johnson and Johnson
- Allergan
- Avid Radiopharmaceuticals